David R Van Wagoner

Author PubWeight™ 82.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inflammation as a risk factor for atrial fibrillation. Circulation 2003 4.95
2 GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science 2013 4.71
3 Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 2010 3.97
4 Genome-wide association study of PR interval. Nat Genet 2010 3.73
5 Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012 3.71
6 Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation 2009 3.50
7 Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail 2009 2.09
8 Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo. Cardiovasc Res 2004 2.04
9 Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation 2012 1.81
10 Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg 2006 1.71
11 Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation 2007 1.68
12 L-type calcium channel blockers exert an antiinflammatory effect by suppressing expression of plasminogen receptors on macrophages. Circ Res 2009 1.62
13 Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol 2010 1.49
14 Effect of epivascular cardiac autonomic nerve stimulation on cardiac function. Ann Thorac Surg 2012 1.43
15 Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes. Circ Res 2003 1.24
16 Atrial glutathione content, calcium current, and contractility. J Biol Chem 2007 1.19
17 Systems approach to understanding electromechanical activity in the human heart: a national heart, lung, and blood institute workshop summary. Circulation 2008 1.17
18 Elucidation of a TRPC6-TRPC5 channel cascade that restricts endothelial cell movement. Mol Biol Cell 2008 1.17
19 Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation. Am J Cardiol 2004 1.15
20 Whole genome expression differences in human left and right atria ascertained by RNA sequencing. Circ Cardiovasc Genet 2012 1.12
21 Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol 2010 1.11
22 Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation 2014 1.11
23 A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2010 1.09
24 New hope for the prevention of recurrent atrial fibrillation. Eur Heart J 2004 1.08
25 Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias. Am J Physiol Heart Circ Physiol 2007 1.06
26 Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythm Electrophysiol 2010 1.02
27 Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 2004 1.01
28 Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model. Cardiovasc Res 2010 1.01
29 A Randomized, Placebo-Controlled Trial of Omega-3 Fatty Acids for Inhibition of Supraventricular Arrhythmias After Cardiac Surgery: The FISH Trial. J Am Heart Assoc 2012 1.00
30 Role of inflammation in atrial fibrillation pathophysiology and management. Circ J 2015 0.99
31 Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na+/Ca2+-exchange. Cardiovasc Res 2006 0.99
32 Localization of Kv1.5 channels in rat and canine myocyte sarcolemma. FEBS Lett 2006 0.97
33 American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association. Circulation 2011 0.97
34 Impact of dietary fatty acids on cardiac arrhythmogenesis. Circ Arrhythm Electrophysiol 2009 0.94
35 Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling. Int J Cardiol 2013 0.93
36 Influence of race on atrial fibrillation after cardiac surgery. Circ Arrhythm Electrophysiol 2011 0.87
37 Effect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo-controlled trial. J Cardiothorac Vasc Anesth 2006 0.87
38 Cardiac autonomic nerve stimulation in the treatment of heart failure. Ann Thorac Surg 2013 0.86
39 Weighted gene coexpression network analysis of human left atrial tissue identifies gene modules associated with atrial fibrillation. Circ Cardiovasc Genet 2013 0.86
40 Atrial fibrillation: therapy with omega-3 fatty acids-is the case closed? Nat Rev Cardiol 2011 0.81
41 An experimental rabbit model for off-pump left ventricular reconstruction following left ventricular aneurysm. Heart Surg Forum 2006 0.80
42 Low prevalence of connexin-40 gene variants in atrial tissues and blood from atrial fibrillation subjects. BMC Med Genet 2012 0.80
43 Preoperative angiotensin-blocking drug therapy is not associated with atrial fibrillation after cardiac surgery. Am Heart J 2010 0.80
44 Impact of vagal nerve stimulation on left atrial structure and function in a canine high-rate pacing model. Circ Heart Fail 2014 0.80
45 Chronic vagal nerve stimulation for the treatment of human heart failure: progress in translating a vision into reality. Eur Heart J 2010 0.80
46 Insights into mechanisms linking cardiac hypertrophy and atrial fibrosis: evidence for a role of histone deacetylase in atrial fibrillation pathophysiology and therapy. J Mol Cell Cardiol 2008 0.78
47 Phosphodiesterase-4 activity: a critical modulator of atrial contractility and arrhythmogenesis. J Am Coll Cardiol 2012 0.78
48 Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation. Cardiovasc Res 2013 0.77
49 Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update. J Cardiovasc Pharmacol 2015 0.77
50 Plakophilin-2 mutations as a cause of arrhythmogenic right ventricular cardiomyopathy: progress toward linking structural with functional changes. Heart Rhythm 2008 0.77
51 Effects of percutaneous stimulation of both sympathetic and parasympathetic cardiac autonomic nerves on cardiac function in dogs. Innovations (Phila) 2012 0.76
52 Is homocysteine a mediator of atrial dysfunction or just another marker of endothelial dysfunction? Europace 2008 0.76
53 A simplified method for identification of human cardiac myosin heavy-chain isoforms. Biotechnol Appl Biochem 2003 0.76
54 Colchicine for the prevention of postoperative atrial fibrillation: a new indication for a very old drug? Circulation 2011 0.75
55 What currents underlie pulmonary vein automaticity? J Cardiovasc Electrophysiol 2015 0.75
56 Baroreflex stimulation versus renal denervation for treatment of hypertension: what constitutes a logical comparison of these interventions on atrial electrophysiology? J Cardiovasc Electrophysiol 2013 0.75
57 Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery. Heart Rhythm 2012 0.75
58 Full report from the first annual Heart Rhythm Society Research Forum: a vision for our research future, "dream, discover, develop, deliver". Heart Rhythm 2011 0.75
59 Evaluating the impact of atrial dilatation on atrial calcium cycling. Eur Heart J 2008 0.75
60 Multi-channel blockers for treatment of atrial fibrillation: an effective strategy? Cardiovasc Res 2013 0.75
61 Diet and atrial fibrillation: does α-linolenic acid, a plant derived essential fatty acid, have an impact? J Am Heart Assoc 2013 0.75
62 Metaboelectric signaling in the diseased heart. J Mol Cell Cardiol 2006 0.75
63 Better never than late? New insights into a mechanism linking metabolic stress to altered cardiac repolarization. J Mol Cell Cardiol 2007 0.75
64 Aldosterone antagonism as an antiarrhythmic approach for atrial arrhythmias in heart failure. J Cardiovasc Electrophysiol 2006 0.75
65 Fish oil for atrial fibrillation prevention: can we intervene soon enough to make a difference? Heart Rhythm 2012 0.75
66 Fifteen Genetic Loci Associated With the Electrocardiographic P Wave. Circ Cardiovasc Genet 2017 0.75
67 Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet 2017 0.75